Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Vulcan Biologics
company
About
Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of microbiomes.
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $0.98M
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2019
- Operating Status
- Active
Vulcan Biologics provides a biotechnology platform that offers stable and persistent modulation of the microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiome. Its platform uses bacteriophages that alter the gut bacterias of the microbiome that helps in the treatment of gluten-related disorders like gluten sensitivity and celiac disease.Vulcan Biologics was founded in 2019 and is headquartered in Irvine, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$0.98M
Vulcan Biologics has raised a total of
$0.98M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2021 | Grant | $0.98M | 1 |
National Science Foundation
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Vulcan Biologics has made 1 investments. Their most recent investment was on
May 1, 2013, when Mirakl Target2Sell raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 1, 2013
Mirakl Target2Sell
|
Seed | — | Artificial Intelligence | — |
Investors
Number of Lead Investors
Number of Investors
1
1
Vulcan Biologics is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
